Cargando…

Correction to: Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c

Detalles Bibliográficos
Autores principales: Yao, Jian, Hui, Jian-wen, Chen, Yan-jun, Luo, Dong-yang, Yan, Jiang-shu, Zhang, Yi-fan, Lan, Yuan-xiang, Yan, Xiu-rui, Wang, Zhi-hua, Fan, Heng, Xia, He-chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425283/
https://www.ncbi.nlm.nih.gov/pubmed/37138098
http://dx.doi.org/10.1038/s41417-023-00620-3
_version_ 1785089803994267648
author Yao, Jian
Hui, Jian-wen
Chen, Yan-jun
Luo, Dong-yang
Yan, Jiang-shu
Zhang, Yi-fan
Lan, Yuan-xiang
Yan, Xiu-rui
Wang, Zhi-hua
Fan, Heng
Xia, He-chun
author_facet Yao, Jian
Hui, Jian-wen
Chen, Yan-jun
Luo, Dong-yang
Yan, Jiang-shu
Zhang, Yi-fan
Lan, Yuan-xiang
Yan, Xiu-rui
Wang, Zhi-hua
Fan, Heng
Xia, He-chun
author_sort Yao, Jian
collection PubMed
description
format Online
Article
Text
id pubmed-10425283
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-104252832023-08-16 Correction to: Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c Yao, Jian Hui, Jian-wen Chen, Yan-jun Luo, Dong-yang Yan, Jiang-shu Zhang, Yi-fan Lan, Yuan-xiang Yan, Xiu-rui Wang, Zhi-hua Fan, Heng Xia, He-chun Cancer Gene Ther Correction Nature Publishing Group US 2023-05-03 2023 /pmc/articles/PMC10425283/ /pubmed/37138098 http://dx.doi.org/10.1038/s41417-023-00620-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correction
Yao, Jian
Hui, Jian-wen
Chen, Yan-jun
Luo, Dong-yang
Yan, Jiang-shu
Zhang, Yi-fan
Lan, Yuan-xiang
Yan, Xiu-rui
Wang, Zhi-hua
Fan, Heng
Xia, He-chun
Correction to: Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c
title Correction to: Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c
title_full Correction to: Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c
title_fullStr Correction to: Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c
title_full_unstemmed Correction to: Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c
title_short Correction to: Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c
title_sort correction to: lycium barbarum glycopeptide targets per2 to inhibit lipogenesis in glioblastoma by downregulating srebp1c
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425283/
https://www.ncbi.nlm.nih.gov/pubmed/37138098
http://dx.doi.org/10.1038/s41417-023-00620-3
work_keys_str_mv AT yaojian correctiontolyciumbarbarumglycopeptidetargetsper2toinhibitlipogenesisinglioblastomabydownregulatingsrebp1c
AT huijianwen correctiontolyciumbarbarumglycopeptidetargetsper2toinhibitlipogenesisinglioblastomabydownregulatingsrebp1c
AT chenyanjun correctiontolyciumbarbarumglycopeptidetargetsper2toinhibitlipogenesisinglioblastomabydownregulatingsrebp1c
AT luodongyang correctiontolyciumbarbarumglycopeptidetargetsper2toinhibitlipogenesisinglioblastomabydownregulatingsrebp1c
AT yanjiangshu correctiontolyciumbarbarumglycopeptidetargetsper2toinhibitlipogenesisinglioblastomabydownregulatingsrebp1c
AT zhangyifan correctiontolyciumbarbarumglycopeptidetargetsper2toinhibitlipogenesisinglioblastomabydownregulatingsrebp1c
AT lanyuanxiang correctiontolyciumbarbarumglycopeptidetargetsper2toinhibitlipogenesisinglioblastomabydownregulatingsrebp1c
AT yanxiurui correctiontolyciumbarbarumglycopeptidetargetsper2toinhibitlipogenesisinglioblastomabydownregulatingsrebp1c
AT wangzhihua correctiontolyciumbarbarumglycopeptidetargetsper2toinhibitlipogenesisinglioblastomabydownregulatingsrebp1c
AT fanheng correctiontolyciumbarbarumglycopeptidetargetsper2toinhibitlipogenesisinglioblastomabydownregulatingsrebp1c
AT xiahechun correctiontolyciumbarbarumglycopeptidetargetsper2toinhibitlipogenesisinglioblastomabydownregulatingsrebp1c